180 related articles for article (PubMed ID: 35569973)
1. The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenström's Macroglobulinemia.
Sekiguchi N
Intern Med; 2022 Dec; 61(23):3473-3474. PubMed ID: 35569973
[No Abstract] [Full Text] [Related]
2. [Complete response with tirabrutinib for relapsed and refractory Bing-Neel syndrome].
Hagihara M; Ide S; Ohara S; Imai Y; Uchida T; Inoue M
Rinsho Ketsueki; 2022; 63(7):770-775. PubMed ID: 35922946
[TBL] [Abstract][Full Text] [Related]
3. Bing-Neel Syndrome Successfully Treated with Tirabrutinib.
Oyama T; Taoka K; Chiba A; Matsuda K; Maki H; Masamoto Y; Kurokawa M
Intern Med; 2022 Dec; 61(23):3575-3579. PubMed ID: 35569989
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with tirabrutinib for relapsed lymphoplasmacytic lymphoma complicated by Bing-Neel syndrome.
Saburi M; Saburi Y; Kawano K; Sato R; Urabe S; Ohtsuka E
Int J Hematol; 2022 Apr; 115(4):585-589. PubMed ID: 34699012
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib for the treatment of Bing-Neel syndrome, a complication of Waldenström macroglobulinemia: Patient case report.
Hartsell L; Janes A; Larck C; Park S; Arnall JR
J Oncol Pharm Pract; 2019 Sep; 25(6):1534-1539. PubMed ID: 30760164
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemia.
Sekiguchi N; Rai S; Munakata W; Suzuki K; Handa H; Shibayama H; Endo T; Terui Y; Iwaki N; Fukuhara N; Tatetsu H; Iida S; Ishikawa T; Shiibashi R; Izutsu K
Cancer Sci; 2020 Sep; 111(9):3327-3337. PubMed ID: 32639651
[TBL] [Abstract][Full Text] [Related]
7. [Bing-Neel syndrome successfully treated with tirabrutinib].
Yokoyama K; Ohigashi H; Miyajima T; Miyashita N; Okada S; Hasegawa Y; Sugita J; Onozawa M; Hashimoto D; Teshima T
Rinsho Ketsueki; 2022; 63(8):870-875. PubMed ID: 36058857
[TBL] [Abstract][Full Text] [Related]
8. Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia.
Sekiguchi N; Rai S; Munakata W; Suzuki K; Handa H; Shibayama H; Endo T; Terui Y; Iwaki N; Fukuhara N; Tatetsu H; Iida S; Ishikawa T; Iguchi D; Izutsu K
Cancer Sci; 2022 Jun; 113(6):2085-2096. PubMed ID: 35332633
[TBL] [Abstract][Full Text] [Related]
9. Rare case of Bing-Neel syndrome treated successfully with ibrutinib.
Hashmi H; Dhanoa JS; Emmons R
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31243026
[TBL] [Abstract][Full Text] [Related]
10. Bing-Neel syndrome: A case reports.
Demircioğlu S; Oltulu P; Emlik GD; Tekinalp A; Çeneli Ö
J Oncol Pharm Pract; 2021 Oct; 27(7):1758-1761. PubMed ID: 33356992
[TBL] [Abstract][Full Text] [Related]
11. Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib.
Sekiguchi Y; Nishimura Y; Kanda H; Kawamura M; Kobayashi K; Kobayashi H
Intern Med; 2022 Aug; 61(16):2503-2508. PubMed ID: 35110483
[TBL] [Abstract][Full Text] [Related]
12. [Waldenström's macroglobulinemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case].
Quilichini R; Benderitter T; Lafeuillade A; Chaffanjon P; Aubert L
Ann Med Interne (Paris); 1989; 140(1):25-9. PubMed ID: 2500048
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].
Sekiguchi N
Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201
[TBL] [Abstract][Full Text] [Related]
14. Bing-Neel syndrome with a paravertebral mass.
Suzuki D; Sato D; Kikuchi K; Suzuki T; Sugasawa K; Saito S; Uchimura F; Suzuki Y
Am J Med Sci; 2023 Oct; 366(4):316-320. PubMed ID: 37473959
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
Kim HD; Shin KC; Cho HS; Kim MK; Lee KH; Hyun MS
J Korean Med Sci; 2007 Dec; 22(6):1079-81. PubMed ID: 18162727
[TBL] [Abstract][Full Text] [Related]
16. Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Jafri H; Khan I; Sidda A; Khan NAJ; Kheetan M; Griswold D; Pacioles T
J Investig Med High Impact Case Rep; 2021; 9():23247096211021228. PubMed ID: 34078157
[TBL] [Abstract][Full Text] [Related]
17. Bing-Neel syndrome revealing Waldenström's macroglobulinemia: a case report.
Jennane S; El Maaroufi H; Mahtat EM; Mikdame M; Doghmi K
Tunis Med; 2020 Oct; 98(10):750-753. PubMed ID: 33479948
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation.
Saburi M; Sakata M; Okuhiro K; Kawano K; Uesugi S; Wada J; Urabe S; Saburi Y; Ohtsuka E
J Clin Exp Hematop; 2022; 62(3):181-186. PubMed ID: 36171098
[TBL] [Abstract][Full Text] [Related]
19. Rituximab and ibrutinib in the treatment of Waldenström's macroglobulinemia.
Grunenberg A; Buske C
Future Oncol; 2019 Aug; 15(23):2687-2697. PubMed ID: 31184501
[TBL] [Abstract][Full Text] [Related]
20. Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature.
Varettoni M; Defrancesco I; Diamanti L; Marchioni E; Farina LM; Pichiecchio A
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017061. PubMed ID: 29181138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
